May 31, 2023
Peter Grinspoon MD
Kathryn interviews Simon N. Whitney MD JD. Faced with horrors such as the notorious Tuskegee syphilis study, another experiment that injected patients with live cancer cells, and a third that infected institutionalized children with hepatitis, one might expect only praise for a regulatory system intended to promote safe and ethical medical research. Simon N. Whitney is part of a chorus of critics who argue that this regulatory regime needlessly burdens researchers and stifles the advance of life-saving medical treatments. He sees regulation as an essential part of modern life, but maintains that regulations need to reflect real world research if they are to serve their mission. He presents vivid case studies of how vital breakthroughs for treating heart disease, premature births and kidney stones have been inexcusably delayed forcing doctors and patients to settle for less effective treatments.He is a graduate of NYU Medical School, Stanford Law School and was previously on the faculty at Baylor College of Medicine.Kathryn also interviews Peter Grinspoon MD.One in seven Americans uses some sort of CBD product. 94 percent of Americans support legalization of medical marijuana and 69 percent want total legalization. Whether it’s the hard-dying, fear-mongering lies spun by the War on Drugs and other prohibition campaigns or the utopian daydreams of long-time stoners and evangelists, we’re still confused about the leaf that we have been using for at least five-thousand years. Peter Grinspoon, physician and cannabis expert draws from a wealth of scientific research, clinical practice, and personal experience to demystify marijuana. He is a primary care physician and cannabis specialist at Massachusetts General Hospital and an instructor in Medicine at Harvard Medical School. He regularly appears as an expert on Good Morning America, NPR’s All Things Considered, NBC Nightly News and C-SPAN’s Washington Journal and is quoted frequently in the NY Times, Washington Post, Boston Globe and the Wall Street Journal.